Skip to Main Content

Paper Details

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.
Clin Infect Dis
112
2017
CD4+, CD4+ T cells, CD8+, CD8+ T cells, HIV, HIV infection, HIV-1, HIV-1-infected, Human, Human Immunodeficiency Virus Infection, ISG15, LRA, MGN1703, Mx1, NK, OAS1, RNA, TLR9, Toll-Like Receptor 9, Toll-like receptor 9, cytotoxic NK cell, cytotoxic NK cells, human immunodeficiency virus type 1, infected cells, interferon-stimulated genes, natural killer, participants, plasma HIV-1 RNA, plasma interferon-2, plasmacytoid, plasmacytoid dendritic cell, plasmacytoid dendritic cells
Author NameAffiliation
Tao DengBlood Systems Research Institute
Tao DengUniversity of California san francisco
Satish K PillaiBlood Systems Research Institute
Satish K PillaiUniversity of California san francisco
  • 1 - 4

Datasets

Release 1.2